Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Cryptos Muted As Fed Meet Looms
-
$ETH: CME Group Shows Impeccable Timing With Launch of Its Options on Ether Futures
-
RAPT Therapeutics Slips 9% After Pricing Public Offering
-
$BTC: BitMEX Co-Founder Offers Two Possible Explanations for Bitcoin’s Current Rally
-
NuScale Power Rallies After Standard Power Selecting Its SMR Technology